跳至主要内容
临床试验/NCT07302464
NCT07302464已完成不适用

Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Estimated Glomerular Filtration Rate in Diabetic Versus Non-Diabetic Chronic Kidney Disease Patients

Ain Shams University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
60
试验地点
1
主要终点
Change in the estimated glomerular filtration rate

研究概览

简要总结

The work aimed to compare the effects of Sodium-glucose co-transporter-2 (SGLT2) inhibitors on glomerular filtration rate (GFR) in patients with diabetic chronic kidney disease (CKD) and non-diabetic CKD.

详细描述

Glucose reabsorption is mediated by the sodium-glucose cotransporter (SGLT) 2, which reabsorbs 90% of glucose, and SGLT1, which reabsorbs the remaining 10%.

The relationship between hyperglycaemia and the development of renal disease is complex. Hyperglycaemia-induced complications are mediated by several metabolic pathways, among which accumulation of Advanced Glycation End-products with abnormalities of the glycosylation of macromolecules and increased glucose flux through the polyol pathway seem to be the most important.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 years.
  • Both sexes.
  • Chronic kidney disease (CKD) participants with stages 3 and 4.

排除标准

  • Patients with type 1 diabetes mellitus (DM).
  • Patients with decompensated Chronic liver disease.
  • Patients with uncontrolled hypertension.
  • Patients with blood pressure (BP) > 110/
  • Patients already on the same medication (Sodium Glucose Co-Transporter 2 Inhibitors).
  • Patients with a history of recurrent or recent urinary tract infection (UTI).
  • Patients with glycated hemoglobin (HbA1c) ≤
  • Adult polycystic kidney disease.
  • All patients on immunosuppressive medications.

结局指标

主要结局

Change in the estimated glomerular filtration rate

时间窗: 6 months post-procedure

Change in the estimated glomerular filtration rate (eGFR) was recorded.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ashraf Hassan

Assistant Professor of Internal Medicine and Nephrology, Faculty of Medicine, Ain shams University, Cairo, Egypt

Ain Shams University

研究点 (1)

Loading locations...

相似试验

Sodium Glucose Co-Transporter 2 Inhibitors on... | 临床试验